Medicine
Ziprasidone 60 mg capsule
Ziprasidone 60 mg capsule is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Bottles of 60 NDC 16714-838-01 Ziprasidone capsules, USP should be stored at…
Key facts
- Active ingredient (INN)
- Ziprasidone
- Brand
- Sold under the generic name
- Strength
- 60 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 60 capsules, 8 blister pack, 1000 capsules and 31 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaRemedyrepackBryant Ranch PrepackProficient RxMajor PharmaceuticalsAmerican Health PackagingApotexAvPAK
- Origin register
- US FDA, United States
- Storage
- Bottles of 60 NDC 16714-838-01 Ziprasidone capsules, USP should be stored at 20° to 25°C (68° to 77°F),excursions permitted to 15° to 30°C(59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AE04 Ziprasidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 March 2012
- Identifiers
- RxCUI 313776, 313777, 313778 +1DailyMed set ID 0071a228-21cc-56a6-dcc9-a7a6ceea758c, a66a0b25-673c-4a3d-b923-5f65a02b8ff0, ba039e48-7bde-4fc5-bd39-8c9dfa98fada +13NDC 16714-837, 70518-0782, 68084-105 +13Application ANDA077565, ANDA204375, ANDA077561 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 capsule in 1 bottle | 65862-704-60 | Aurobindo PharmaIndia | 27 December 2016 |
| 8 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-704-80 | Aurobindo PharmaIndia | 27 December 2016 |
| 1000 capsule in 1 bottle | 65862-704-99 | Aurobindo PharmaIndia | 27 December 2016 |
| 100 capsule in 1 bottle | 55111-258-01 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 500 capsule in 1 bottle | 55111-258-05 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 30 capsule in 1 bottle | 55111-258-30 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 60 capsule in 1 bottle | 55111-258-60 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 55111-258-78 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 3 blister pack in 1 carton / 10 capsule in 1 blister pack | 55111-258-81 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 90 capsule in 1 bottle | 55111-258-90 | Dr. Reddy's LaboratoriesIndia | 2 March 2012 |
| 60 capsule in 1 bottle | 33342-146-09 | Macleods PharmaceuticalsIndia | 18 February 2017 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 33342-146-12 | Macleods PharmaceuticalsIndia | 18 February 2017 |
| 300 capsule in 1 bottle | 33342-146-51 | Macleods PharmaceuticalsIndia | 18 February 2017 |
| 60 capsule in 1 bottle | 60505-2530-6 | Apotex | 14 May 2012 |
| 60 capsule in 1 bottle | 62135-993-60 | Chartwell RX | 28 April 2023 |
| 30 capsule in 1 bottle | 71335-0585-1 | Bryant Ranch Prepack | 4 April 2018 |
| 28 capsule in 1 bottle | 71335-0585-2 | Bryant Ranch Prepack | 28 June 2022 |
| 30 capsule in 1 bottle | 71335-9761-1 | Bryant Ranch Prepack | 11 August 2023 |
| 28 capsule in 1 bottle | 71335-9761-2 | Bryant Ranch Prepack | 11 August 2023 |
| 30 pouch in 1 box / 1 capsule in 1 pouch | 70518-0782-1 | Remedyrepack | 24 March 2025 |
| 50 pouch in 1 box / 1 capsule in 1 pouch | 70518-0782-3 | Remedyrepack | 9 July 2026 |
| 30 capsule in 1 blister pack | 70518-4475-0 | Remedyrepack | 11 September 2025 |
| 30 pouch in 1 box / 1 capsule in 1 pouch | 70518-4475-1 | Remedyrepack | 10 October 2025 |
| 50 pouch in 1 box / 1 capsule in 1 pouch | 70518-4475-3 | Remedyrepack | 8 July 2026 |
| 80 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack | 68084-105-09 | American Health Packaging | 16 December 2014 |
| 20 blister pack in 1 box / 1 capsule in 1 blister pack | 50268-813-12 | AvPAK | 12 May 2021 |
| 60 capsule in 1 bottle | 68001-452-06 | BluePoint Laboratories | 31 August 2020 |
| 60 capsule in 1 bottle | 60429-767-60 | Golden State Medical Supply | 20 July 2012 |
| 40 blister pack in 1 carton / 1 capsule in 1 blister pack | 0904-6271-08 | Major Pharmaceuticals | 15 March 2012 |
| 80 blister pack in 1 carton / 1 capsule in 1 blister pack | 0904-6271-45 | Major Pharmaceuticals | 15 March 2012 |
| 60 capsule in 1 bottle | 16714-837-01 | NorthStar Rx | 26 July 2018 |
| 30 capsule in 1 bottle | 63187-578-30 | Proficient Rx | 1 December 2018 |
| 60 capsule in 1 bottle | 63187-578-60 | Proficient Rx | 1 December 2018 |
| 90 capsule in 1 bottle | 63187-578-90 | Proficient Rx | 1 December 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 February 2001 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ziprasidone 60 mg capsule.
Other strengths and forms of Ziprasidone
Clinical summary
Ziprasidone is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as capsules and powder for injection for oral and intramuscular use. MedsAcross supplies Ziprasidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ZiprasidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Geodon prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Ziprasidone 60 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.